Brief: Bajaj Healthcare Receives CDSCO Approval For Suvorexant Tablets Trial
31/12/2025 14:22
Dec 31 (Reuters) - Bajaj Healthcare Ltd BAJH.NS: RECEIVES CDSCO APPROVAL FOR SUVOREXANT TABLETS TRIAL Source text: ID:nBSE8Fb7pz Further company coverage: BAJH.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bajaj Healthcare
See all newsBrief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees
Brief: Bajaj Healthcare Receives CDSCO Approval For Suvorexant Tablets Trial
India's Bajaj Healthcare rises as insomnia pill trial gets regulatory nod
Brief: Bajaj Healthcare Posts June-Quarter Profit Of 118.3 Million Rupees